Biotech Stocks Under Consideration - HEB, SQNM, MNKD, PPHM

Pompano Beach, FL -- (SBWIRE) -- 01/07/2013 -- HemispherxBioPharma, Inc (NYSEAMEX:HEB) percentage change jumped +10.43% to close at $0.269 with the total traded volume of 4.88 million shares more than average volume of 5.01 million shares.

Company’s lowest price during last trade was $0.23 while its highest price remained $0.27 for the day. HEB’s total market capitalization is $40.61 million along with 151.01 million shares outstanding. Its beta value stands at 1.24 points and its earning per shares remained $-0.11.

Has HEB Found The Bottom and Ready To Move Up? Find Out Here

Sequenom, Inc. (NASDAQ:SQNM) reported an upsurge of +3.56% after opening at the price of $5.02 its closing price for the day was $5.23.

SQNM’s total trading volume for the day was 4.33 million shares versus its average volume of 3.09 million shares. Company’s current market capitalization stands at $600.33 million along with 114.79million shares. Sequenom Company’s earning per share is $-0.97 while its beta value stands at 0.20 times.

Sequenom, Inc. (NASDAQ:SQNM) is providing innovative diagnostic testing and genetic analysis solutions. It is a life science company,recently reported that, On Wednesday, January 9th,it will participate the Annual JP Morgan Healthcare Conference.

Harry F. Hixson, Jr., Ph.D.,the CEO and Chairman of the company and Director &EVP of Strategic Planning Mr. Lindsay, Ph.D both will join conference and will provide the updates and overviews of the company. The conference will be hosted at 11:30 am PT (2:30 pm ET) on Westin St. Francis Hotel in San Francisco, CA.

Has SQNM Found The Bottom And Ready To Gain Momentum? Find Out Here

One more hot stock under review is MannKind Corporation(NASDAQ:MNKD), its percentage change climbed 4.18% to close at $2.49 with the total traded volume of4.18 million shares less than average volume of 2.41million.

Its market capitalization is $611.99 million and EPS was $-1.02. Its beta value stands at 1.06 times. MNKD’s shares were trading within the range of $2.39-$2.55while its opening price was $2.40.

If we look at previous three months trade, it declined -8.79% while in last 5 day’s it remained up 4.62%.MannKind Corporation’s focal point is developing discovering and commercializing curing for cancer and diabetes, the company reported that onThursday, January 10, 2013 at 8:00 AM (PST)it will present at The 31st Annual J.P. Morgan Healthcare Conference which is going to beheld on St. Francis Hotel in San Francisco, California.

Why Should Investors Buy MNKDAfter the Recent Fall? Just Go Here and Find Out

Peregrine Pharmaceuticals (NASDAQ:PPHM) reported the gain of +6.30% and closed at $1.35 with the total traded volume of 3.62 million shares, stock’s opening price was $1.28. The company has total of 132.54 million outstanding shares and its total market capitalization is $178.93 million.

52-week price range of the stock remained $0.39 - $5.50, while during last trade its minimum price was $1.25 and it gained highest price of $0.39. Company’s last 5 days shows an uptrend with upsurge of 14.41%.

Will PPHM Get Buyers Even After The Recent Rally? Find Out Here

About TopStockPlays
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.

Disclaimer
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.